Why is there discordance between the reimbursement of high-cost 'life-extending'pharmaceuticals and medical devices? The funding of ventricular assist devices in …
S Saing, N van der Linden, C Hayward… - … health economics and …, 2019 - Springer
New health technologies often yield health benefits, but often at a high cost. In Australia, the
processes for public reimbursement of high-cost pharmaceuticals and medical devices are …
processes for public reimbursement of high-cost pharmaceuticals and medical devices are …
[图书][B] Modelling the cost-effectiveness of strategies to treat end-stage heart failure using discrete event simulation
S Saing - 2021 - search.proquest.com
The cost of providing healthcare is increasing due to an ageing population and new
technologies, hence the assessments of value for money are becoming more important …
technologies, hence the assessments of value for money are becoming more important …
Costs before and after left ventricular assist device implant and preceding heart transplant: a cohort study
Background Up to 50% of heart transplant candidates require bridging with left ventricular
assist devices (VAD). This study describes hospital activity and cost 1 year preceding and 1 …
assist devices (VAD). This study describes hospital activity and cost 1 year preceding and 1 …